Featured Research

from universities, journals, and other organizations

OHSU Researchers Discover New Synapses In Brain

Date:
May 17, 2000
Source:
Oregon Health Sciences University
Summary:
For decades, scientists have known that nerve cells in the brain communicate with each other through high-speed contacts called synapses. Now, researchers at Oregon Health Sciences University's Vollum Institute and the University of Oxford have discovered that synapses also are used to communicate with other specialized brain cells called oligodendrocytes.

Portland, Ore. -- For decades, scientists have known that nerve cells in the brain communicate with each other through high-speed contacts called synapses. Now, researchers at Oregon Health Sciences University's Vollum Institute and the University of Oxford have discovered that synapses also are used to communicate with other specialized brain cells called oligodendrocytes. Studying these previously unknown synapses may provide a key for understanding brain function in health and disease. These results appear in the May 11 edition of the journal Nature.

Oligodendrocytes produce myelin, a sheath that surrounds and insulates nerve fibers. This insulation allows nerve fibers to transmit signals at high speed, like the signals from spinal cord to the muscles of the leg. The breakdown of myelin around these nerve fibers is believed to be the cause of multiple sclerosis.

Scientists at OHSU, in collaboration with colleagues at the Medical Research Council Unit at Oxford, have found that the oligodendrocytes taking part in this communication are in their immature stage and do not produce myelin. Previous work has shown that glutamate, the chemical used to transmit signals at these synapses, can inhibit the development of these cells into the mature, myelin-producing oligodendrocytes. These newly discovered connections may help answer many remaining questions about how nerve cells regulate myelin formation.

While the research team stresses their basic science finding is years away from providing treatment options for MS patients, they hope to continue to build on this work to further the understanding of the beneficial and detrimental nerve communications that take place in the brain.

"It is our hope that continued research will lead to treatments that will stimulate the maturation of these immature oligodendrocytes to allow re-myelination to occur after injury or disease," said Dwight Bergles, Ph.D., a postdoctoral fellow at OHSU and lead author of the paper. "However, it is likely that we still face years of research before this work travels from the scientist's bench to the patient's bedside."

Researchers used two separate techniques to discover these connections. OHSU scientists recorded the tiny electrical signals generated at the synapses between nerve cells and oligodendrocytes. Their collaborators in the MRC Unit at Oxford, Professor Peter Somogyi, Ph.D., D.Sc., and J. David B. Roberts used an electron microscope to see the cell junctions or synapses where the nerve signals are being transmitted.

"Scientists are just beginning to understand the processes through which cells of the brain communicate with one another," said Craig Jahr, Ph.D., a senior scientist at OHSU's Vollum Institute and co-author of the study. "In the future we hope to learn more about what happens when these lines of communication are broken and what we can do to repair them or prevent further damage."

This work was supported by funds from the National Institutes of Health and the Medical Research Council, UK.


Story Source:

The above story is based on materials provided by Oregon Health Sciences University. Note: Materials may be edited for content and length.


Cite This Page:

Oregon Health Sciences University. "OHSU Researchers Discover New Synapses In Brain." ScienceDaily. ScienceDaily, 17 May 2000. <www.sciencedaily.com/releases/2000/05/000516072110.htm>.
Oregon Health Sciences University. (2000, May 17). OHSU Researchers Discover New Synapses In Brain. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2000/05/000516072110.htm
Oregon Health Sciences University. "OHSU Researchers Discover New Synapses In Brain." ScienceDaily. www.sciencedaily.com/releases/2000/05/000516072110.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins